跳至主要内容
临床试验/NCT01333488
NCT01333488终止2 期

A Phase 2, Randomized, Controlled 2x3 Trial Comparing Clinical Outcomes in Patients With Severe Traumatic Brain Injury Using Mild Hypothermia and Concurrent and Supplemental Infusion of Magnesium Sulfate.

United States Department of Defense1 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2011年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
终止
入组人数
6
试验地点
1
主要终点
GOS (Glasgow Outcome Score)

研究概览

简要总结

The investigators hypothesize that hypothermia (body cooling) and additional magnesium sulfate will improve the outcome of severe Traumatic Brain Injury (TBI) patients.

This is a study to compare the outcomes of patients with severe traumatic brain injury who have been allocated to one of the following three groups:

Group 1 - Conventional therapy following traumatic brain injury Group 2 - Subjects will have their core body temperature lowered to 34C Group 3 - Subjects will have their core body temperature lowered to 34C and will receive a supplemental intravenous infusion of magnesium sulfate.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult males or females ≥ 18 years of age
  • Subjects with Traumatic Brain Injury and a post-resuscitation Glasgow Coma Score (GCS) ≤ 8
  • In-hospital and screened within 7 hours of injury.
  • Able to obtain legally effective written consent from authorized representative
  • Patients who are intubated and on mechanical ventilation
  • Admitted to ICU

排除标准

  • Bladder or rectal core temperature below 32C (89.6F) upon admission
  • Clinical brain death
  • Patients with open abdomens.
  • Multiple orthopedic injuries (> 2 long bone fractures)
  • Persistent hypotension (systolic blood pressure < 90mmHg)
  • Persistent hypoxia (O2 Saturation < 94%)
  • Persistent metabolic acidosis (Lactic acid > 5 mmol/L, arterial pH < 7.25)
  • Positive serum pregnancy test
  • Cardiac arrhythmia with deleterious hemodynamic effects; heart block or myocardial damage (as shown on ECG)
  • History of abnormal renal function
  • Significant Co-morbidity (i.e. CAD;COPD; severe coagulopathy)
  • Pediatric patients (< 18 years old)

研究组 & 干预措施

Hypothermia

Experimental

Subjects will have their core body temperatures lowered to 34C.

干预措施: Arctic Sun (Device)

Hypothermia plus supplemental magnesium sulfate infusion

Experimental

干预措施: Arctic Sun (Device)

Hypothermia plus supplemental magnesium sulfate infusion

Experimental

干预措施: Magnesium Sulfate (Drug)

结局指标

主要结局

GOS (Glasgow Outcome Score)

时间窗: Discharge from Hospital - Within 2 months from Injury

GOS=5 (Good Recovery) - Capacity to resume normal occupational and social activities, although some there may be some minor physical or mental deficits or symptoms. GOS=4 (Moderate Disability) - Independent and can resume almost all activities of daily living. GOS=3 (Severe Disability) - No longer capable of engaging in most previous personal, social or work activities. Typically are partially or totally dependent on assistance from others in daily living. GOS=2 ( Persistent Vegetative State ) GOS=1 (Dead)

次要结局

  • GOS(12 months after injury)
  • Vasospasm(up to 3 months)

研究者

申办方类型
Fed
责任方
Principal Investigator
主要研究者

Greg Zorman

Chief of Neurosurgery

United States Department of Defense

研究点 (1)

Loading locations...

相似试验

Mild Hypothermia and Supplemental Magnesium Sulfate... | 临床试验